D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
GE Aerospace
GE
|
+$499M |
| 2 |
Meta Platforms (Facebook)
META
|
+$468M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$331M |
| 4 |
Merck
MRK
|
+$312M |
| 5 |
MON
Monsanto Co
MON
|
+$245M |
Top Sells
| 1 |
Apple
AAPL
|
+$440M |
| 2 |
Netflix
NFLX
|
+$300M |
| 3 |
Verizon
VZ
|
+$253M |
| 4 |
Tesla
TSLA
|
+$241M |
| 5 |
Alibaba
BABA
|
+$236M |
Sector Composition
| 1 | Technology | 17.21% |
| 2 | Healthcare | 14.64% |
| 3 | Consumer Discretionary | 11.67% |
| 4 | Communication Services | 10.42% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
QCR Holdings
QCRH
$1.32B
| $678K | ﹤0.01% |
15,812
+414
| +3% | +$17.8K |
|
1927
Andersons Inc
ANDE
$1.34B
| $673K | ﹤0.01% |
21,592
+926
| +4% | +$28.9K |
|
1928
Northwest Bancshares
NWBI
$1.83B
| $673K | ﹤0.01% |
40,228
+25,036
| +165% | +$419K |
|
1929
Trex
TREX
$6.47B
| $672K | ﹤0.01% |
+24,800
| New | +$672K |
|
|
ONC
1930
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.8B
| $671K | ﹤0.01% |
6,866
-13,173
| -66% | -$1.29M |
|
1931
Virtus Investment Partners
VRTS
$1.31B
| $667K | ﹤0.01% |
+5,794
| New | +$667K |
|
1932
First Foundation Inc
FFWM
$484M
| $666K | ﹤0.01% |
35,899
-15,142
| -30% | -$281K |
|
1933
Apple Hospitality REIT
APLE
$2.98B
| $666K | ﹤0.01% |
33,950
-125,983
| -79% | -$2.47M |
|
1934
Helmerich & Payne
HP
$2.02B
| $659K | ﹤0.01% |
10,188
-5,700
| -36% | -$369K |
|
1935
NOV
NOV
$4.76B
| $656K | ﹤0.01% |
18,219
+4,529
| +33% | +$163K |
|
|
OXFD
1936
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $652K | ﹤0.01% |
46,636
-11,005
| -19% | -$154K |
|
1937
CubeSmart
CUBE
$9.31B
| $650K | ﹤0.01% |
22,489
-45,234
| -67% | -$1.31M |
|
1938
Protagonist Therapeutics
PTGX
$3.58B
| $650K | ﹤0.01% |
+31,251
| New | +$650K |
|
|
TPCO
1939
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $650K | ﹤0.01% |
+36,958
| New | +$650K |
|
|
CPN
1940
DELISTED
Calpine Corporation
CPN
| $650K | ﹤0.01% |
42,981
-566
| -1% | -$8.56K |
|
1941
MillerKnoll
MLKN
$1.38B
| $647K | ﹤0.01% |
16,156
+10,502
| +186% | +$421K |
|
1942
Tucows
TCX
$193M
| $647K | ﹤0.01% |
+9,239
| New | +$647K |
|
1943
CytomX Therapeutics
CTMX
$346M
| $643K | ﹤0.01% |
30,481
+17,998
| +144% | +$380K |
|
1944
Nelnet
NNI
$4.45B
| $642K | ﹤0.01% |
11,720
-9,306
| -44% | -$510K |
|
1945
SEI Investments
SEIC
$10.7B
| $642K | ﹤0.01% |
+8,933
| New | +$642K |
|
|
KEM
1946
DELISTED
KEMET Corporation
KEM
| $640K | ﹤0.01% |
42,496
-485,019
| -92% | -$7.3M |
|
1947
New Jersey Resources
NJR
$4.65B
| $639K | ﹤0.01% |
15,885
-17,261
| -52% | -$694K |
|
|
FTR
1948
DELISTED
Frontier Communications Corp.
FTR
| $639K | ﹤0.01% |
94,586
+60,176
| +175% | +$407K |
|
1949
Ameriprise Financial
AMP
$46.4B
| $637K | ﹤0.01% |
3,759
+1,459
| +63% | +$247K |
|
1950
Brookfield
BN
$101B
| $637K | ﹤0.01% |
+27,375
| New | +$637K |
|